Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07054489 · ClinicalTrials.gov registry record · NA
UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF
A NA study of Heart Failure and Polygenic Score, sponsored by David Lanfear.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07054489 is a NA study of Heart Failure and Polygenic Score that is actively recruiting participants, run by David Lanfear. The registered enrollment target is 10 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07054489, a NA study of Heart Failure and Polygenic Score, is actively recruiting participants, sponsored by David Lanfear.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will use polygenic scores, a tool which describes differences in genetics, to examine effectiveness of beta blocker medication in heart failure patients with ejection fraction of 41-50 percent. The study will also assess beta blockers' effect on the changes in left ventricular end-systolic volume index by MRI.
Conditions Studied
Interventions
- OTHER Beta blocker
Study Locations (1)
Michigan
- Henry Ford Health - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-11 |
| Est. Completion | 2026-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07054489
The ClinicalTrials.gov registry entry for NCT07054489 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (100% lower). The listed sponsor is David Lanfear, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Beta blocker is the first listed.
NCT07054489 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07054489 about?
NCT07054489 is a clinical study titled "UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF". This study will use polygenic scores, a tool which describes differences in genetics, to examine effectiveness of beta blocker medication in heart failure patients with ejection fraction of 41-50 percent. The study will also assess beta blockers' effect on the changes in left ventricular end-systoli...
What is the current status of trial NCT07054489?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-11. Estimated completion is 2026-11.
What conditions does trial NCT07054489 study?
This clinical trial studies the following conditions: Heart Failure, Polygenic Score.
What interventions are being tested in trial NCT07054489?
The interventions under investigation include: Beta blocker (OTHER).
Who is sponsoring clinical trial NCT07054489?
This trial is sponsored by David Lanfear, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07054489 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.